Literature DB >> 22469482

Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity.

A Tursi1, W Elisei, G Brandimarte, G M Giorgetti, C D Inchingolo, R Nenna, M Picchio, F Giorgio, E Ierardi.   

Abstract

AIM: Inflammation occurs in diverticular disease (DD), but there is little information on inflammatory cytokines such as tumour necrosis factor α (TNF-α). The aim of this study was to assess TNF-α expression in DD and to see whether it is related to the severity of the disease.
METHOD: Twenty-four patients with symptomatic DD were divided into those with acute uncomplicated diverticulitis (AUD) (12 patients) and those with symptomatic uncomplicated diverticular disease (SUDD) (12 patients). Twelve further patients with asymptomatic diverticulosis (AD), six with segmental colitis associated with diverticulosis (SCAD), with ulcerative colitis (UC) and six healthy individuals (HC) were enrolled as controls. TNF-α expression in the colonic mucosa was assessed by the amount of mRNA codifying for the synthesis of TNF-α.
RESULTS: TNF-α expression was significantly higher in AUD than in HC (P=0.0007), in AD (P=0.0001) and in SUDD (P=0.0179). It was significantly higher also in SUDD than in HC (P=0.0007) and in AD (P=0.0001). TNF-α expression in AUD did not differ significantly from that in UC (P=0.0678) and SCAD (P=0.0610). It was significantly higher in UC, SCAD and AUD than in SUDD (P=0.0007, P=0.0001, P=0.0179).
CONCLUSION: TNF-α expression in DD seems to be related to the severity of the disease. In particular, it appears to be overexpressed in DD with inflammation (AUD and SUDD) compared with DD without (AD).
© 2012 The Authors. Colorectal Disease © 2012 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469482     DOI: 10.1111/j.1463-1318.2012.02926.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  12 in total

1.  Preventing recurrent acute diverticulitis with pharmacological therapies.

Authors:  Antonio Tursi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

2.  Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

Authors:  R Caruso; I Marafini; E Franzè; C Stolfi; F Zorzi; I Monteleone; F Caprioli; A Colantoni; M Sarra; S Sedda; L Biancone; P Sileri; G S Sica; T T MacDonald; F Pallone; G Monteleone
Journal:  Mucosal Immunol       Date:  2014-05-21       Impact factor: 7.313

Review 3.  Advances in the management of colonic diverticulitis.

Authors:  Antonio Tursi
Journal:  CMAJ       Date:  2012-08-27       Impact factor: 8.262

4.  The role of body composition in diverticular disease.

Authors:  Julia Freckelton; Darcy Holt; Adina Borsaru; StellaMay Gwini; Daniel Croagh; Gregory Moore
Journal:  Int J Colorectal Dis       Date:  2018-04-18       Impact factor: 2.571

Review 5.  Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.

Authors:  Eleonora Scaioli; Antonio Colecchia; Giovanni Marasco; Ramona Schiumerini; Davide Festi
Journal:  Dig Dis Sci       Date:  2015-10-12       Impact factor: 3.199

Review 6.  The Pathophysiology of Colonic Diverticulosis: Inflammation versus Constipation?

Authors:  Walter Elisei; Antonio Tursi
Journal:  Inflamm Intest Dis       Date:  2018-06-28

7.  Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort.

Authors:  Adi Lahat; Herma H Fidder; Shomron Ben-Horin
Journal:  Therap Adv Gastroenterol       Date:  2020-05-08       Impact factor: 4.409

Review 8.  Role of Inflammation in Pathophysiology of Colonic Disease: An Update.

Authors:  Noha Ahmed Nasef; Sunali Mehta
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

9.  Cross-sectional analysis of obesity and serum analytes in males identifies sRAGE as a novel biomarker inversely associated with diverticulosis.

Authors:  Sarah S Comstock; Markita M Lewis; Dorothy R Pathak; Kari Hortos; Bruce Kovan; Jenifer I Fenton
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

Review 10.  Progress and challenges in the management of diverticular disease: which treatment?

Authors:  Angel Lanas; Daniel Abad-Baroja; Aitor Lanas-Gimeno
Journal:  Therap Adv Gastroenterol       Date:  2018-07-23       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.